2 Popular Stocks to Avoid in April and Beyond
Novavax made a huge bet on the coronavirus vaccine market early in the pandemic. Many people expressed skepticism regarding the mRNA-based candidates that dominated the hunt for an effective vaccine early on, but Novavax's Nuvaxovid is a protein-based vaccine.